DRUG Stock-Based Compensation
Bright Minds Biosciences Inc · Stock-Based Compensation
DRUG Stock-Based Compensation
Latest reported$2.35M CADperiod ending
DRUG Stock-Based Comp · CAD ($0.00 → $2.35M)
Annual stock-based compensation
High-resolution chart · PNG
DRUG stock-based compensation history
Annual fiscal periods · CAD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (CAD) |
|---|---|
| 3,182,703 | |
| 839,771 | |
| 1,152,131 | |
| 875,056 | |
| 880,615 | |
| 161,300 | |
| 0 |